Hemogenyx Pharmaceuticals Earnings Per Share vs. Number Of Employees
| HEMO Stock | 343.40 20.90 6.48% |
For Hemogenyx Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hemogenyx Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hemogenyx Pharmaceuticals PLC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hemogenyx Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hemogenyx Pharmaceuticals PLC over time as well as its relative position and ranking within its peers.
Hemogenyx |
Hemogenyx Pharmaceuticals Number Of Employees vs. Earnings Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Hemogenyx Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Hemogenyx Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Hemogenyx Pharmaceuticals PLC is one of the top stocks in earnings per share category among its peers. It also is one of the top stocks in number of employees category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hemogenyx Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Hemogenyx Number Of Employees vs. Earnings Per Share
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Hemogenyx Pharmaceuticals |
| = | (2.00) X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Hemogenyx Pharmaceuticals |
| = | 17 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Hemogenyx Number Of Employees vs Competition
Hemogenyx Pharmaceuticals PLC is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 18,202. Hemogenyx Pharmaceuticals adds roughly 17.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Hemogenyx Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Hemogenyx Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hemogenyx Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Hemogenyx Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Hemogenyx Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.1 M | 1.1 M | |
| Operating Income | -6.5 M | -6.1 M | |
| Income Before Tax | -6.7 M | -6.4 M | |
| Net Loss | -6.7 M | -6.4 M | |
| Total Other Income Expense Net | -230.6 K | -242.2 K | |
| Income Tax Expense | -5.8 K | -5.5 K | |
| Interest Income | 85.3 K | 89.6 K | |
| Net Loss | -6.7 M | -6.4 M | |
| Net Loss | -4.6 M | -4.4 M | |
| Net Interest Income | -230.6 K | -242.2 K | |
| Change To Netincome | 725.5 K | 845.2 K |
Hemogenyx Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Hemogenyx Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hemogenyx Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hemogenyx Pharmaceuticals' important profitability drivers and their relationship over time.
Use Hemogenyx Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hemogenyx Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemogenyx Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Hemogenyx Pharmaceuticals Pair Trading
Hemogenyx Pharmaceuticals PLC Pair Trading Analysis
The ability to find closely correlated positions to Hemogenyx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hemogenyx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hemogenyx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hemogenyx Pharmaceuticals PLC to buy it.
The correlation of Hemogenyx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hemogenyx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hemogenyx Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hemogenyx Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Hemogenyx Pharmaceuticals position
In addition to having Hemogenyx Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Machinery Thematic Idea Now
Machinery
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Machinery theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Machinery Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.